FDA To Consider More Studies Of Vertex/CRISPR Sickle Cell Gene Therapy
U.S. FDA’s team of reviewers has requested that the regulatory advisory panel assess the requirement for additional studies on the…
U.S. FDA’s team of reviewers has requested that the regulatory advisory panel assess the requirement for additional studies on the…
Arialys Therapeutics has secured $58 million in seed funding for the development of treatments targeting autoimmune neuropsychiatric diseases. Arialys Therapeutics,…
2seventy bio, Inc. and JW Therapeutics, a biotech firm focusing on cell immunotherapy products, have announced their intent to broaden…
Seamless Therapeutics has received $12.5 million in seed funding to advance a revolutionary gene editing platform based on programmable precision…
Audentes Therapeutics has reported a third death in a clinical trial of its gene therapy against a rare genetic neuromuscular…
Foldamers are sequence-specific oligomers parallel to peptides, proteins and oligonucleotides among the aim of fold up into precise three-dimensional arrangements.…